CONMED Corporation (CNMD)

Currency in USD
46.30
-0.68(-1.45%)
Closed·
46.19-0.11(-0.24%)
·
CNMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
45.2446.78
52 wk Range
31.4456.64
Key Statistics
Prev. Close
46.3
Open
45.6
Day's Range
45.24-46.78
52 wk Range
31.44-56.64
Volume
641.52K
Average Volume (3m)
621.74K
1-Year Change
-11.4553%
Book Value / Share
34.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
45.50
Downside
-1.73%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

CONMED Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

0 Buy
6 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 45.50
(-1.73% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BMO Capital
Hold45.00-2.81%36.00Maintain30/07/2026
JPMorgan
Hold45.00-2.81%40.00Maintain30/07/2026
Wells Fargo
Hold46.00-0.65%39.00Maintain30/07/2026
Piper Sandler
Hold45.00-2.81%39.00Maintain30/07/2026
Needham
Hold---Maintain14/07/2026

CONMED Corporation Earnings Call Summary for Q2/2026

  • CONMED Q2 adjusted EPS of $1.38 beat estimates by 24%, though $0.21 came from one-time tariff refund; revenue rose 0.3% to $343.5M, up 6% organically.
  • Gross margin expanded 300bps to 59.5% on tariff refund and product mix; AirSeal, Buffalo Filter, and BioBrace drove growth across surgery segments.
  • Full-year EPS guidance raised to $4.48-$4.60 from $4.30-$4.45; organic revenue growth narrowed to 5-6% from 5-6.5% amid slower second-half outlook.
  • Q3 guidance calls for revenue of $334M-$339M with 6.4-7.6% organic growth and adjusted EPS of $0.98-$1.03; stock unchanged after-hours at $43.21.
  • Company faces $0.35/share tariff headwind for 2026 and flat U.S. orthopedic sales; debt stands at $834M with 2.9x leverage after refinancing.
Last Updated: 30/07/2026, 07:44 am
Read Full Transcript

Earnings

Latest Release
29/07/2026
EPS / Forecast
1.38 / 1.11
Revenue / Forecast
343.5M / 337.46M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.84%
Dividend Yield
1.70%
Industry Median 1.53%
Annualised payout
0.80
Paid quarterly
5-Years Growth
-24.21%
Growth Streak

CNMD Income Statement

Compare CNMD to Peers and Sector

Metrics to compare
CNMD
Peers
Sector
Relationship
P/E Ratio
24.5x35.7x−0.4x
PEG Ratio
−0.510.770.00
Price/Book
1.3x4.5x2.6x
Price / LTM Sales
1.0x3.1x3.0x
Upside (Analyst Target)
−2.8%12.4%56.0%
Fair Value Upside
Unlock20.8%9.1%Unlock

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.52M54.88%765.08M
Other Institutional Investors
17.97M45.12%832.03M
Public Companies & Retail Investors
0.000.00%0.00
Total
34.49M100.00%1.6B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.16.11%4,825,173223,406
EARNEST Partners, LLC8.58%2,569,653118,975

People Also Watch

42.80
BLKB
+6.79%
178.16
ENSG
-0.37%
32.65
CEVA
-0.73%
93.93
ZBH
-1.08%

FAQ

What Is the CONMED (CNMD) Stock Price Today?

The CONMED stock price today is 46.30 USD.

What Stock Exchange Does CONMED Trade On?

CONMED is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for CONMED?

The stock symbol for CONMED is "CNMD."

Does CONMED Pay Dividends? What’s The Current Dividend Yield?

The CONMED dividend yield is 1.7%.

What Is the CONMED Market Cap?

As of today, CONMED market cap is 1.39B USD.

What Is CONMED's Earnings Per Share (TTM)?

The CONMED EPS (TTM) is 1.84.

When Is the Next CONMED Earnings Date?

CONMED will release its next earnings report on 28/10/2026.

From a Technical Analysis Perspective, Is CNMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has CONMED Stock Split?

CONMED has split 3 times.

How Many Employees Does CONMED Have?

CONMED has 3900 employees.

What is the current trading status of CONMED (CNMD)?

As of 03/08/2026, CONMED (CNMD) is trading at a price of 46.30 USD, with a previous close of 46.30 USD. The stock has fluctuated within a day range of 45.24 USD to 46.78 USD, while its 52-week range spans from 31.44 USD to 56.64 USD.

What Is CONMED (CNMD) Price Target According to Analysts?

The average 12-month price target for CONMED is 45.50 USD, with a high estimate of 49 USD and a low estimate of 43 USD. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -1.73% Downside potential.

What Is the CNMD After Hours Price?

CNMD's last after hours stock price is 46.19 USD, the stock has decreased by -0.11, or -0.24%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.